Bipinesh's profile picture. MD, DM Medical Oncology Interests - #SelfcareforDoctors #Gerionc #IntegrativeOncology #medoncovns #Gynaeonco #Sarcoma #Rarecancers #Supportivecareinoncology

Bipinesh Sansar

@Bipinesh

MD, DM Medical Oncology Interests - #SelfcareforDoctors #Gerionc #IntegrativeOncology #medoncovns #Gynaeonco #Sarcoma #Rarecancers #Supportivecareinoncology

Bipinesh Sansar reposted

Our new paper in IJMPO explores how genetic clinics can transform hereditary cancer care in India & LMICs. Early detection, family screening & personalized therapy must be made accessible & equitable. 🔗 doi.org/10.1055/s-0045… #Oncology #Genetics #CancerCare @TMC_Varanasi

drakhilkapoor1's tweet image. Our new paper in IJMPO explores how genetic clinics can transform hereditary cancer care in India & LMICs.
Early detection, family screening & personalized therapy must be made accessible & equitable.

🔗 doi.org/10.1055/s-0045…
#Oncology #Genetics #CancerCare

@TMC_Varanasi

Bipinesh Sansar reposted

Thrilled to see our work on oral metronomic chemotherapy featured by Prof. David Kerr (@UniofOxford) on MEDSCAPE ! 📰 “The Global Applicability of Oral Metronomic Chemotherapy” 🔗 medscape.com/viewarticle/gl… Pushing the boundaries to equitable cancer care! #GlobalOnco @TMC_Varanasi

drakhilkapoor1's tweet image. Thrilled to see our work on oral metronomic chemotherapy featured by Prof. David Kerr (@UniofOxford) on MEDSCAPE !

📰 “The Global Applicability of Oral Metronomic Chemotherapy”
🔗 medscape.com/viewarticle/gl…
Pushing the boundaries to equitable cancer care!
#GlobalOnco @TMC_Varanasi
drakhilkapoor1's tweet image. Thrilled to see our work on oral metronomic chemotherapy featured by Prof. David Kerr (@UniofOxford) on MEDSCAPE !

📰 “The Global Applicability of Oral Metronomic Chemotherapy”
🔗 medscape.com/viewarticle/gl…
Pushing the boundaries to equitable cancer care!
#GlobalOnco @TMC_Varanasi

Bipinesh Sansar reposted

Scottie Scheffler just gave one of the best (and deepest) press conference answers ever heard.


Bipinesh Sansar reposted

🔔Oncologists, enhance your pain management skills! Join the online course on Advanced Pain Management. 📅 14 Aug–23 Oct | ⏰ 7–8:30 PM | 💻 Zoom 🎓 Certificate on completion To Register, please visit: palliumindia.org/2025/07/web-ba… #Oncology #PainManagement #MedX #RegisterNow

palliumindia's tweet image. 🔔Oncologists, enhance your pain management skills! Join the online course on Advanced Pain Management.

📅 14 Aug–23 Oct | ⏰ 7–8:30 PM | 💻 Zoom
🎓 Certificate on completion

To Register, please visit: palliumindia.org/2025/07/web-ba…

#Oncology #PainManagement #MedX #RegisterNow

Bipinesh Sansar reposted

Why is it so hard for people, especially some wellness influencers, to admit this simple truth…. You can do everything right. You can eat the kale, take the supplements, walk 10k steps a day, lift the weights, meditate, sleep 8 hours, avoid sugar, avoid seed oils, avoid…


Bipinesh Sansar reposted
DrYukselUrun's tweet image. Every oncologist is a patient advocate.
Right treatment. 
Right time. 
For every patient.
#ASCO25 #Oncology #CancerCare #AccessMatters
@oncoalert @ASCO @DrChoueiri @yekeduz_emre @CParkMD @PGrivasMDPhD @TwoOncDocs @OncBrothers @Larvol @VivekSubbiah @ASCOPres @AmericanCancer @WHO…

Bipinesh Sansar reposted

🚨 Just published in JCO Global Oncology 📢 Our phase III METRO-CHASE trial shows triple oral metronomic chemotherapy significantly improves survival in platinum-refractory. #HeadAndNeckCancer. 🔗 doi.org/10.1200/GO-25-… #oncology #cancerresearch


Bipinesh Sansar reposted

Educational Series- 2 Unveil the Power of PET-CT Scans with Dr. Rachita Rungta (@rachitarungta7), Expert Nuclear Medicine Physician in Mumbai – Precision Meets Insight for Smarter Diagnoses 🔬✨ Watch here- youtu.be/SIrZFh1Uarw #PETCTScan #DrRachitaRungta #NuclearMedicine

LungConnectIN's tweet card. Role of PET-CT Scan in Lung Cancer by Dr Rachita Rungta | Expert Talk...

youtube.com

YouTube

Role of PET-CT Scan in Lung Cancer by Dr Rachita Rungta | Expert Talk...


x.com/MoHFW_INDIA/st… A very useful additional help for geriatric cancer patients - Ayushman card for those aged 70 years and above @drakhilkapoor1 @LungConnectIN @IndianCancerSoc @Amolpatel_dr

#AyushmanBharat | Senior citizens aged 70 and above can now get their Ayushman Vay Vandana Card through the Ayushman App and access ₹5 lakh of free treatment. Watch this video to learn how to create Ayushman Vay Vandana Card and unlock essential healthcare benefits.…



Bipinesh Sansar reposted

#AyushmanBharat | Senior citizens aged 70 and above can now get their Ayushman Vay Vandana Card through the Ayushman App and access ₹5 lakh of free treatment. Watch this video to learn how to create Ayushman Vay Vandana Card and unlock essential healthcare benefits.…


Bipinesh Sansar reposted

FDA grants accelerated approval to a treatment for KRAS-mutated recurrent low-grade serous ovarian cancer. fda.gov/drugs/resource…

FDAOncology's tweet image. FDA grants accelerated approval to a treatment for KRAS-mutated recurrent low-grade serous ovarian cancer.
fda.gov/drugs/resource…

Bipinesh Sansar reposted

👉 Join the experts developing and implementing the widely used #ESMOGuidelines in this live presentation of a real-world case in #bladdercancer. With #ESMOOnAir, from the convenience of your preferred device, anywhere. 🔗 ow.ly/rrhl50V5UcS

myESMO's tweet image. 👉 Join the experts developing and implementing the widely used #ESMOGuidelines in this live presentation of a real-world case in #bladdercancer. With #ESMOOnAir, from the convenience of your preferred device, anywhere.

🔗 ow.ly/rrhl50V5UcS

Bipinesh Sansar reposted

Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers. Every step forward is a step toward hope. Together, we can fight, raise awareness & inspire @Bipinesh Great work #CancerSupport #FightCancer #IndiaDetectsToDefeat

drakhilkapoor1's tweet image. Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers.

Every step forward is a step toward hope. 

Together, we can fight, raise awareness & inspire
@Bipinesh Great work

#CancerSupport #FightCancer #IndiaDetectsToDefeat
drakhilkapoor1's tweet image. Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers.

Every step forward is a step toward hope. 

Together, we can fight, raise awareness & inspire
@Bipinesh Great work

#CancerSupport #FightCancer #IndiaDetectsToDefeat
drakhilkapoor1's tweet image. Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers.

Every step forward is a step toward hope. 

Together, we can fight, raise awareness & inspire
@Bipinesh Great work

#CancerSupport #FightCancer #IndiaDetectsToDefeat
drakhilkapoor1's tweet image. Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers.

Every step forward is a step toward hope. 

Together, we can fight, raise awareness & inspire
@Bipinesh Great work

#CancerSupport #FightCancer #IndiaDetectsToDefeat

Bipinesh Sansar reposted

Proud to present our latest guidelines: Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pedia… pubmed.ncbi.nlm.nih.gov/39212863/ @hepinternation1 @ESPGHANSociety @ILBS_India @ispghan


Bipinesh Sansar reposted

Perhaps the first Triveoctin PET of India @TMC_Varanasi Case of GBM IDH wild type Triveoctin targets αvβ8-Integrin which is a potent modulator of the immune system and an activator of transforming growth factor β (TGFβ). Its increased expression is seen in gliomas

the_nuclear_doc's tweet image. Perhaps the first Triveoctin PET of India @TMC_Varanasi 

Case of GBM IDH wild type 

Triveoctin targets αvβ8-Integrin which is a potent modulator of the immune system and an activator of transforming growth factor β (TGFβ). Its increased expression is seen in gliomas

Bipinesh Sansar reposted

Perhaps the First PDL1 PET/CT of India PDL1 PET/CT is a non invasive investigation which gives a novel insight into the PDL1 expression of the whole body tumor burden. Limitation of Biopsy-it gives expression of only that site, which may not be representative of the whole body.

the_nuclear_doc's tweet image. Perhaps the First PDL1 PET/CT of India

PDL1 PET/CT is a non invasive investigation which gives a novel insight into the PDL1 expression of the whole body tumor burden. Limitation of Biopsy-it gives expression of only that site, which may not be representative of the whole body.

Bipinesh Sansar reposted

Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch

CRSTonline's tweet image. Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch
CRSTonline's tweet image. Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch
CRSTonline's tweet image. Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch
CRSTonline's tweet image. Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch

Bipinesh Sansar reposted

Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. Both significant PFS and OS benefit, somewhat similar to CETUXI. Immediately practice changing for those who can't afford IO/Cetuximab. @ASCOPost @Bipinesh @csoncol @SuyogCancer

drakhilkapoor1's tweet image. Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. 
Both significant PFS and OS benefit, somewhat similar to CETUXI.
Immediately practice changing for those who can't afford IO/Cetuximab. 
@ASCOPost @Bipinesh @csoncol @SuyogCancer
drakhilkapoor1's tweet image. Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. 
Both significant PFS and OS benefit, somewhat similar to CETUXI.
Immediately practice changing for those who can't afford IO/Cetuximab. 
@ASCOPost @Bipinesh @csoncol @SuyogCancer
drakhilkapoor1's tweet image. Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. 
Both significant PFS and OS benefit, somewhat similar to CETUXI.
Immediately practice changing for those who can't afford IO/Cetuximab. 
@ASCOPost @Bipinesh @csoncol @SuyogCancer
drakhilkapoor1's tweet image. Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. 
Both significant PFS and OS benefit, somewhat similar to CETUXI.
Immediately practice changing for those who can't afford IO/Cetuximab. 
@ASCOPost @Bipinesh @csoncol @SuyogCancer

Bipinesh Sansar reposted

Join the MedEd CoP #ASCO24 session IN ONE HOUR! Find us in S103, 7:30-9:30 AM! #MedEd #Oncology #OncMedEd #ASCOMedEdCoP

OncMedEdCoP's tweet image. Join the MedEd CoP #ASCO24 session IN ONE HOUR!  Find us in S103, 7:30-9:30 AM!  #MedEd #Oncology #OncMedEd #ASCOMedEdCoP

Bipinesh Sansar reposted

A physician who cares about their wellbeing is not "uncommitted" to medicine. They've seen doctors leave the field (and sadly, die by suicide). What you see is not disinterest, but survival. An attempt to protect their longevity in this field & the care they give to patients.


Loading...

Something went wrong.


Something went wrong.